BIOMAT Database Logo BIOMAT Database Logo

Clostridium difficile--setting the scene. 1998

M H Wilcox
Department of Microbiology, University of Leeds and The General Infirmary, UK. markwi@pathology.leeds.ac.uk

UI MeSH Term Description Entries
D003428 Cross Infection Any infection which a patient contracts in a health-care institution. Hospital Infections,Nosocomial Infections,Health Care Associated Infection,Health Care Associated Infections,Healthcare Associated Infections,Infection, Cross,Infections, Hospital,Infections, Nosocomial,Cross Infections,Healthcare Associated Infection,Hospital Infection,Infection, Healthcare Associated,Infection, Hospital,Infection, Nosocomial,Infections, Cross,Infections, Healthcare Associated,Nosocomial Infection
D004761 Enterocolitis, Pseudomembranous An acute inflammation of the INTESTINAL MUCOSA that is characterized by the presence of pseudomembranes or plaques in the SMALL INTESTINE (pseudomembranous enteritis) and the LARGE INTESTINE (pseudomembranous colitis). It is commonly associated with antibiotic therapy and CLOSTRIDIUM DIFFICILE colonization. Antibiotic-Associated Colitis,Clostridium Enterocolitis,Colitis, Pseudomembranous,Enteritis, Pseudomembranous,Pseudomembranous Colitis,Pseudomembranous Enteritis,Pseudomembranous Enterocolitis,Antibiotic Associated Colitis,Colitis, Antibiotic-Associated
D006113 United Kingdom Country in northwestern Europe including Great Britain and the northern one-sixth of the island of Ireland, located between the North Sea and north Atlantic Ocean. The capital is London. Great Britain,Isle of Man
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial
D015994 Incidence The number of new cases of a given disease during a given period in a specified population. It also is used for the rate at which new events occur in a defined population. It is differentiated from PREVALENCE, which refers to all cases in the population at a given time. Attack Rate,Cumulative Incidence,Incidence Proportion,Incidence Rate,Person-time Rate,Secondary Attack Rate,Attack Rate, Secondary,Attack Rates,Cumulative Incidences,Incidence Proportions,Incidence Rates,Incidence, Cumulative,Incidences,Person time Rate,Person-time Rates,Proportion, Incidence,Rate, Attack,Rate, Incidence,Rate, Person-time,Rate, Secondary Attack,Secondary Attack Rates
D016360 Clostridioides difficile A common inhabitant of the colon flora in human infants and sometimes in adults. The type species Clostridioides difficile is formerly known as Clostridium difficile. It is a causative agent for CLOSTRIDIOIDES INFECTIONS and is associated with PSEUDOMEMBRANOUS ENTEROCOLITIS in patients receiving antibiotic therapy. Clostridium difficile
D017053 Infection Control Programs of disease surveillance, generally within health care facilities, designed to investigate, prevent, and control the spread of infections and their causative microorganisms. Control, Infection

Related Publications

M H Wilcox
Clostridium difficile in the long-term care setting.
June 2007, Journal of the American Medical Directors Association,
M H Wilcox
Control of Clostridium difficile infection in the hospital setting.
April 2014, Expert review of anti-infective therapy,
M H Wilcox
Antibiotics and Clostridium difficile diarrhea in the ambulatory care setting.
January 2000, Clinical therapeutics,
M H Wilcox
Treatment of clostridium difficile colitis in the critical care setting.
April 2008, Critical care clinics,
M H Wilcox
Clostridium difficile infection in an endemic setting in the Netherlands.
April 2011, European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology,
M H Wilcox
Clostridium difficile Screening for Colonization During an Outbreak Setting.
November 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,
M H Wilcox
Mortality and Clostridium difficile infection in an Australian setting.
October 2013, Journal of advanced nursing,
M H Wilcox
Clostridium difficile colitis in the hospital setting: a potentially explosive problem.
June 1990, Infection control and hospital epidemiology,
M H Wilcox
Setting the scene.
March 2022, British journal of community nursing,
M H Wilcox
Setting the scene.
May 1988, Nursing standard (Royal College of Nursing (Great Britain) : 1987),
Copied contents to your clipboard!